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Introduction {#sec1}
============

Nature has created remarkable examples of dye assembly that are vital for sustaining life. For instance, the formation of chlorophyll J-aggregates can afford intense near-infrared (NIR) absorption up to ∼900 nm, which enables the more efficient light harvesting of sunlight ([@bib31]). Organic biomedical materials have been quickly developed in recent years because of their biodegradability, robust biocompatibility, and long-term biological safety ([@bib34], [@bib35], [@bib26], [@bib27], [@bib48]). During the process, the supramolecular strategy plays an increasingly important role as weak noncovalent interactions will influence the properties of organic biomedicines by controlling the molecular packing structure and self-assembly morphology ([@bib10], [@bib45], [@bib39], [@bib38], [@bib2], [@bib3], [@bib4]). For instance, Zheng and co-workers developed porphyrin-lipid conjugates, which self-assembled into porphysome. Although porphyrin has been extensively investigated in biomedical applications, the porphysome shows distinguished optical properties with improved performance in photothermal therapy (PTT) and photoacoustic imaging (PAI) ([@bib21]). In another example, supramolecular complex between cucurbit\[7\]uril and organic conjugated radical was developed by Zhang and co-workers; the organic radical itself suffers from radical annihilation caused by π-π stacking and its NIR absorption would be impaired. Accordingly, in addition to functioning as a drug delivery vehicle, the macrocycle acted as a shield to preserve the organic radical and its absorption, finally making the complex applicable in PTT ([@bib16]).

The NIR cyanine dyes with long-wavelength absorption and high extinction coefficient show great potential in phototheranostics nowadays ([@bib23], [@bib25], [@bib11]). However, as they are vulnerable to photo-irradiation and the complex biological environment ([@bib2], [@bib3], [@bib4], [@bib32]), cyanine dyes are generally complexed with other materials for practical applications, and polymer encapsulation is one of the approaches ([@bib48], [@bib33], [@bib34], [@bib35]). Herein, we report an example of advanced supramolecular medicine between amphiphilic polymer DSPE-PEG~2k~-NH~2~ and indocyanine green (ICG), a representative cyanine dye, in which the beneficial interactions between the polymer carrier and dye bring superior properties to the complex system ([Scheme 1](#sch1){ref-type="fig"}). Rather than a simple encapsulation, these polymer micelles can induce the guest ICG molecules to a complete J-aggregation and enhance their optical properties for phototheranostic applications, i.e., the micelle-encapsulated ICG J-aggregate showed a deeper NIR absorption (a redshift from 780 to 895 nm) with a higher absorption coefficient (78.0 L·g^−1^·cm^−1^ versus 45.0 L·g^−1^·cm^−1^ of free ICG), higher penetration capability, and enhanced photothermal effect and photostability. Recently, the construction of aggregates by noncovalent interaction has been proved to be an effective strategy to improve the function and stability of organic dyes ([@bib36], [@bib9], [@bib8]). Moreover, compared with random aggregation, dye J-aggregate with regular head-to-tail molecular packing featuring a deeper and stronger absorption ([@bib6]) has attracted extensive attentions ([@bib44], [@bib2], [@bib3], [@bib4], [@bib17], [@bib42], [@bib12], [@bib5], [@bib47], [@bib13], [@bib15]). However, the formation of dye J-aggregate and the subsequent biomedical application are challenging, which requires a long formation time at a high concentration and lacks structural stability for *in vivo* application ([@bib20], [@bib41], [@bib7], [@bib40]). In the system that we explored in this article, facilitated by the host-guest interactions of polymer micelles, the ICG molecules in dilute solution can convert to complete J-aggregate within 8 h. What\'s more, the ICG J-aggregate in the supramolecular assembly showed robust stability under intracellular and *in vivo* incubation, making this material more accessible to biomedical applications. To the best of our knowledge, there is rare report on the precise control of dye aggregation by adjusting the host-guest interactions between the polymer carrier and the encapsulated dye. As another benefit of micelle encapsulation, the as-fabricated complex micelle can be functionalized conveniently. In this work, to reach a better therapeutic effect, the negative charge and functional groups of the complex micelle with ICG J-aggregate in encapsulation were employed to introduce doxorubicin (DOX) through electrostatic interaction for chemotherapy and to covalently conjugate DNA aptamer for active tumor targeting ([Scheme 1](#sch1){ref-type="fig"}). The *invivo* anticancer experiment proved that the final multi-functional micellar medicine, which combined J-aggregation-enhanced PTT, aptamer targeting and enhanced permeability and retention (EPR)-promoted tumor enrichment, and chemotherapy based on DOX sustained release, accomplished complete tumor elimination with no local reoccurrence within 24 days. Last but not the least, in addition to the superior therapeutic performance, this micellar medicine showed reliable biocompatibility without long-term toxicity and side effects.Scheme 1Illustration of the Formation of the Supramolecular Medicine Based on Polymer Micelle and ICG J-aggregate and Its Application in PAI-Guided Chemo-phototherapySee also [Table S1](#mmc1){ref-type="supplementary-material"}.

Results and Discussion {#sec2}
======================

Fabrication and Characterization of DSPE-PEG\@ICG-J {#sec2.1}
---------------------------------------------------

ICG aqueous solution showed two absorption peaks at 715 and 780 nm from its monomer and dimer, respectively. Occasionally, we observed an interesting phenomenon that, after being co-dissolved with phospholipid-poly(ethylene glycol), DSPE-PEG~2k~-NH~2~, in ultrapure water and stirred at room temperature for 8 h, ICG showed significantly changed absorption with a shaper and red-shifted peak at 895 nm ([Figures 1](#fig1){ref-type="fig"}A and [S1](#mmc1){ref-type="supplementary-material"}A), which indicates the formation of ICG J-aggregate ([@bib20]). However, without the presence of the micelle polymer, ICG under the same concentration (50 μg·mL^−1^) did not convert to J-aggregate at all, even after a long incubation of 96 h ([Figure 1](#fig1){ref-type="fig"}B), implying the important role of the micelle polymer. In the further study, we observed that ICG J-aggregate did not form with DSPE-PEG polymer without the amine functionalization ([Figures 1](#fig1){ref-type="fig"}C and [S1](#mmc1){ref-type="supplementary-material"}B). It indicated that the positive charge of amine groups probably played an important role. Therefore, we modulated the charge of amine groups by adjusting the pH value. As shown in [Figure 1](#fig1){ref-type="fig"}D, under neutral or alkaline conditions, no ICG J-aggregate formed after an 8-h incubation at room temperature; on the contrary, the majority of free ICG converted to J-aggregate under acidic conditions, and the more acidic the buffer was, the higher the conversion yield achieved. All the results demonstrated that the electrostatic interaction between the positive charge of amine groups and the negatively charged ICG probably is critical for ICG J-aggregation.Figure 1ICG J-aggregation under Different Conditions and ^1^H NMR Characterization(A--E) Monitoring ICG J-aggregation (A) in the presence of DSPE-PEG~2k~-NH~2~ (0.2 mg·mL^−1^) with a 15-min 80°C heating before room temperature stirring in water, (B) in the absence of additive with room temperature stirring in water, (C) in the presence of DSPE-PEG~2k~ or PEG~2k~-NH~2~ (0.2 mg·mL^−1^) with a 24-h room temperature stirring in water, and (D) in the presence of DSPE-PEG~2k~-NH~2~ (0.2 mg·mL^−1^) with room temperature stirring in buffers with various pH values. In these experiments, the concentration of ICG was 50.0 μg·mL^−1^. (E) ^1^H NMR spectra of (I) DSPE-PEG~2k~-NH~2~ micelle, (II) DSPE-PEG~2k~-NH~2~ micelle with ICG J-aggregate in encapsulation, and (III) naked ICG J-aggregate. See also [Figures S1--S3](#mmc1){ref-type="supplementary-material"}.

In addition to the electrostatic interaction, the role of micellar structure formed by DSPE-PEG~2k~-NH~2~ was studied. As a control experiment, PEG~2k~-NH~2~ (both at 0.1--0.3 mg·mL^−1^), which are positively charged molecules but without micellar structure, were incubated with ICG under the same condition as for DSPE-PEG~2k~-NH~2~. However, no conversion trend was observed ([Figures 1](#fig1){ref-type="fig"}C and [S1](#mmc1){ref-type="supplementary-material"}C). This result indicated that the micellar structure would also be necessary for the ICG J-aggregation. Subsequently, the location of ICG J-aggregates in DSPE-PEG~2k~-NH~2~ micelles was analyzed by ^1^H NMR. As shown in [Figures 1](#fig1){ref-type="fig"}E and [S2](#mmc1){ref-type="supplementary-material"}, for the spectrum I of pure DSPE-PEG~2k~-NH~2~ micelles, the resonances of the hydrophobic DSPE core (b and c) and of the hydrophilic PEG shell (a) were well resolved; also, spectrum III of the naked ICG J-aggregates showed sharp resonances. In spectrum II, for the complex between DSPE-PEG~2k~-NH~2~ micelles and ICG J-aggregates, there were a set of resonance peaks showing the same pattern as that of the naked ICG J-aggregates but locating at relatively higher field; meanwhile, the resonances of both the DSPE core and the PEG shell of the DSPE-PEG~2k~-NH~2~ micelle became broader and shifted to a higher field region (a′, b′, and c′). All these resonance changes could be attributed to the shielding effect induced by guest encapsulation ([@bib47], [@bib14]), which fully demonstrated that the ICG molecules were encapsulated in the DSPE-PEG~2k~-NH~2~ micelles under the aggregated state.

Above all, considering the amphiphilic nature of ICG, it can be arranged in the hydrophilic-hydrophobic interface of the micelle after mixing with the amphiphilic DSPE-PEG ([@bib43]). In other words, the hydrophobic core of micelle will attract the head of ICG inside the micellar structure through hydrophobic interaction. At the same time, the positive charges on the micelle outer surface will attract the negatively charged tail of ICG. As a result, the two forces in opposite directions could preset the orientation of ICG in a head-to-tail fashion and cause the ICG J-aggregation. According to the previous studies, naked ICG J-aggregate requires a long formation time. A high concentration of ICG (∼5 mg·mL^−1^) in water could gradually convert to J-aggregate over 1 month ([@bib40]), indicating it was a thermodynamically controlled process in the absence of any external forces. We also found that no J-aggregate formed when an aqueous solution of pure ICG at a high concentration (10.0 mg·mL^−1^) was stirred at room temperature for 24 h, whether at pH 4.0 or 7.0 ([Figure S3](#mmc1){ref-type="supplementary-material"}). Here, a kinetically driven J-aggregation of ICG has been revealed by utilizing the host-guest interaction between polymer micelle and ICG molecules, which will significantly facilitate the process. The obtained micellar assembly between ICG J-aggregate and DSPE-PEG~2k~-NH~2~ is denoted as DSPE-PEG\@ICG-J. The DSPE-PEG\@ICG-J loaded with 33 wt. % ICG J-aggregates was chosen for the following experiments based on careful optimizations ([Figure S4](#mmc1){ref-type="supplementary-material"}). Transmission electron microscopy and dynamic light scattering detections revealed that it was a spherical micelle with an average hydrodynamic diameter of 34.6 nm ([Figure 2](#fig2){ref-type="fig"}A), and its zeta potential was −19.3 mV owing to the presence of negatively charged ICG J-aggregates ([@bib20]).Figure 2Micelle Morphology, *In Vitro* Photothermal Properties, as well as Photo- and Bio-stability of DSPE-PEG\@ICG-J(A) Transmission electron microscopic image and dynamic light scattering analysis result (inset) of DSPE-PEG\@ICG-J.(B) Temperature profiles of PBS buffer (blue dashed line) and DSPE-PEG\@ICG-J solutions at different concentrations (blue solid line) under the irradiation of 880-nm laser (0.8 W·cm^−2^), as well as of PBS buffer (red dash) and free ICG at 50 μg·mL^−1^ (red solid line) under the irradiation of 808-nm laser (0.8 W·cm^−2^).(C--G) (C) The temperature profiles of DSPE-PEG\@ICG-J and free ICG at 50 μg·mL^−1^ under five cycles of laser on-off (0.8 W·cm^−2^; 880-nm laser for DSPE-PEG\@ICG-J; 808-nm laser for free ICG). The absorption spectra of (D) free ICG and (E) DSPE-PEG\@ICG-J before and after 10-min laser irradiation, and the inserts show the before (left) and after (right) photographs. The stability of DSPE-PEG\@ICG-J when incubated in (F) 10% fetal bovine serum or (G) with A549 cells.(H) The fluorescence profiles of DSPE-PEG\@ICG-J (left) and free ICG (right) after they were intravenously injected into mice (150.0 μL, at ICG equivalent concentration of 0.5 mg·mL^−1^).See also [Figures S4](#mmc1){ref-type="supplementary-material"} and [S5](#mmc1){ref-type="supplementary-material"}.

The aggregated ICG in DSPE-PEG\@ICG-J showed a sharp absorption at 895 nm, therefore, in contrast to an 808-nm laser generally used for ICG irradiation, an 880-nm laser can be employed to irradiate DSPE-PEG\@ICG-J in the related applications. The residual energy of the two beams, from an 808-nm and an 880-nm laser, were compared after they passed through pork slides with different thicknesses ([Table S1](#mmc1){ref-type="supplementary-material"}), where the 880-nm laser exhibited a much better tissue penetration capability. The extinction coefficient by weight of ICG J-aggregates in DSPE-PEG\@ICG-J was determined to be 78.0 L·g^−1^·cm^−1^ at 880 nm, which was much higher than that of free ICG at 808 nm (45.0 L·g^−1^·cm^−1^) and many other photothermal materials, such as reduced graphene (∼22.0 L·g^−1^·cm^−1^, 808 nm), single-walled carbon nanotubes (∼46.5 L·g^−1^·cm^−1^, 808 nm), and gold nanorods (∼13.9 L·g^−1^·cm^−1^, 808 nm) ([@bib28], [@bib29]). Meanwhile, DSPE-PEG\@ICG-J showed negligible fluorescence ([Figure S5](#mmc1){ref-type="supplementary-material"}), which probably came from the super-quenching effect of J-aggregates ([@bib22]). Both the enhanced absorption and fluorescence quenching can facilitate the energy conversion from light to heat, therefore at 50 μg·mL^−1^ equivalent concentration of ICG, the temperature of DSPE-PEG\@ICG-J solution increased from 25.3°C to 71.7°C (Δ*T* ∼ 46.4°C) after a 10-min irradiation at 880 nm, whereas that of free ICG solution increased from 25.2°C to 67.1°C (Δ*T* ∼ 41.9°C) under 808 nm irradiation ([Figure 2](#fig2){ref-type="fig"}B). In addition to the superior optical properties, DSPE-PEG\@ICG-J also exhibited excellent photostability. After five cycles of irradiation on-off process, DSPE-PEG\@ICG-J held a consistent photothermal conversion capability, whereas free ICG (50 μg·mL^−1^) could only elevate 18°C in the end ([Figure 2](#fig2){ref-type="fig"}C). We noted that, after a 10-min laser irradiation, the absorption of free ICG decayed significantly, indicating the degradation of ICG molecules ([Figure 2](#fig2){ref-type="fig"}D); however, under the same irradiation time, the absorption spectrum of DSPE-PEG\@ICG-J showed no visible change ([Figure 2](#fig2){ref-type="fig"}E).

The naked ICG J-aggregate suffers from poor intracellular and *in vivo* bio-stability ([@bib20]), which was completely overcome by DSPE- PEG\@ICG-J. After a 24-h incubation in 10% fetal bovine serum (mimicking the biological condition) or a 12-h incubation with A549 cells, the characteristic absorption of ICG J-aggregate in DSPE-PEG\@ICG-J showed no obvious change ([Figures 2](#fig2){ref-type="fig"}F and 2G), demonstrating that the molecular structure and the aggregation state of ICG were well reserved. The *in vivo* structural integration of DSPE-PEG\@ICG-J was investigated through intravenous injection in mice, and the mice injected with free ICG were tested as control. Emitting NIR fluorescence at 845 nm, free ICG can be detected by *in vivo* fluorescence imaging, which is used to indicate the disassembly of ICG J-aggregates in animal body. For the mice injected with free ICG, obvious fluorescence was detected post injection and before the complete metabolism. On the other hand, for the mice injected with DSPE-PEG\@ICG-J, no detectable fluorescence was observed during a 24-h period ([Figure 2](#fig2){ref-type="fig"}H). Thus the ICG J-aggregates in DSPE-PEG\@ICG-J complex micelles show robust stabilities under intracellular and *in vivo* incubations.

Compared with the naked ICG J-aggregate, DSPE-PEG\@ICG-J is convenient to be modified for multi-functionalization, which is another benefit of the hierarchical assembly. First, the amine groups on the PEG shell, which were necessary for the formation of ICG J-aggregate, were utilized to conjugate cancer-targeting ligand after the formation of the complex micelle. A DNA aptamer, AS1411, was selected, which could recognize nucleolin, a specific cellular protein commonly overexpressed on cancer cell membranes ([@bib19]). Through NHS/EDC amidation reaction, a high density of AS1411 aptamers (∼114 μmol·g^−1^) could be coupled on the surface of DSPE-PEG\@ICG-J (the product was named as DSPE-PEG-1411\@ICG-J). Second, due to the negatively charged surface of the complex micelle, a large quantity of positively charged DOX for chemotherapy could be loaded through electrostatic interactions (∼0.2 g DOX on 1.0 g of DSPE-PEG\@ICG-J) ([Scheme 1](#sch1){ref-type="fig"}). We found that the AS1411 conjugation and DOX loading did not alter the aggregation state of ICG ([Figure S6](#mmc1){ref-type="supplementary-material"}A). The fully functionalized micelle was named as DSPE-PEG-1411\@ICG-J/DOX, which showed a hydrodynamic diameter enlarged to 48.4 nm (inset of [Figure S6](#mmc1){ref-type="supplementary-material"}B) and an electrically neutral surface (−1.3 mV). The photothermal properties as well as the photo- and bio-stabilities of this multifunctional micelle were fully characterized according to the same procedures for DSPE-PEG\@ICG-J, and its performances were consistent with those of DSPE-PEG\@ICG-J in all the tests ([Figures S7](#mmc1){ref-type="supplementary-material"}A--S7D), which demonstrated that the incorporation with DOX and DNA aptamer did not affect the photothermal and structural properties of the complex micelle. Subsequently, DOX release from DSPE-PEG-1411\@ICG-J/DOX was monitored over a period of 72 h in PBS buffer (pH 7.4) and HAc-NaAc buffer (pH 5.5), which mimicked the pH values of blood and tumor endosome, respectively ([@bib49]). The DOX release at pH 5.5 was much quicker than that at pH 7.4; in the end, ∼ 90% DOX was released at pH 5.5, whereas only ∼49% of DOX could be released at pH 7.4 ([Figure S7](#mmc1){ref-type="supplementary-material"}E). These results demonstrated that the DOX release from DSPE-PEG-1411\@ICG-J/DOX exhibited a sustained and pH-responsive nature. Taking into account that the *in vivo* application of the micelles would span several weeks, we further evaluated the long-term stability of the micelles at 37°C for 5 weeks. The PBS dispersions of DSPE-PEG\@ICG-J, DSPE-PEG-1411\@ICG-J, and DSPE-PEG-1411\@ICG-J/DOX all maintained excellent colloidal stability at the endpoint, and there is no significant change in their characteristic absorption and the average hydrodynamic diameter of the micelles ([Figure S8](#mmc1){ref-type="supplementary-material"}).

Anticancer Therapy {#sec2.2}
------------------

After coupling with AS1411 aptamer, the cell uptake amount of the complex micelles was about 2.6 times higher than that of their unfunctionalized counterpart on human lung carcinoma A549 cell line overexpressing nucleolin on the cell membrane ([Figure S9](#mmc1){ref-type="supplementary-material"}) ([@bib18]). Coupling with the active targeting, ICG J-aggregate-dominated PTT, and DOX-dominated chemotherapy, DSPE-PEG-1411\@ICG-J/DOX could kill 99.2% A549 cells at an ICG equivalent concentration of 100 μg·mL^−1^ under a 10-min 880-nm laser irradiation (0.8 W·cm^−2^) ([Figures S10](#mmc1){ref-type="supplementary-material"} and [S11](#mmc1){ref-type="supplementary-material"}). Therefore, the *in vivo* anti-tumor efficacies of the micelles based on ICG J-aggregate were systematically evaluated on A549 tumor-bearing BALB/c nude mice. The tumor accumulations of the micelles following intravenous injection were visualized by PAI. Before the *in vivo* PAI, the concentration-dependent photoacoustic signal of the micelles had been confirmed by the *in vitro* studies ([Figure S12](#mmc1){ref-type="supplementary-material"}). All the micelles, DSPE-PEG\@ICG-J, DSPE-PEG-1411\@ICG-J, and DSPE-PEG-1411\@ICG-J/DOX, showed time-dependent accumulation at tumor tissues and reached peak levels at 12 h post the injection ([Figure 3](#fig3){ref-type="fig"}A). Therefore, 12 h post administration was an ideal time point for micelles, whereas the PTT time point for ICG was determined to be 1 h after intravenous administration according to the *in vivo* fluorescence imaging ([Figure S13](#mmc1){ref-type="supplementary-material"}). Subsequently, we examined the tumoral temperature profiles during the *in vivo* PTT. As shown in [Figure 3](#fig3){ref-type="fig"}B, infrared thermography disclosed that the surface temperatures of the tumors in mice treated with DSPE-PEG\@ICG-J, DSPE-PEG-1411\@ICG-J, and DSPE-PEG-1411\@ICG-J/DOX rapidly increased to over 50°C in 4 min and reached peak temperatures of 51.2°C, 54.2°C, and 53.8°C, respectively. In contrast, the highest temperature of the tumor in free ICG-treated mouse reached 44.7°C. The tumor site of PBS-treated mouse showed slight temperature elevation under irradiation, proving no background interference here. It has been reported that strong photothermal heating, which raises the tumor local temperature over 48°C, will result in irreversible tissue damage, whereas the tumor temperature between 40°C and 45°C can only bring sublethal damage to tumor cells ([@bib46]). This declaration was proved by the histopathological tissue analysis following H&E staining of tumor sections from mice after the PTT treatments. As shown in [Figure 4](#fig4){ref-type="fig"}A, compared with free ICG, DSPE-PEG\@ICG-J and DSPE-PEG-1411\@ICG-J resulted in more necrotic areas at the tumor. Moreover, compared with its counterpart without AS1411 conjugation, DSPE-PEG-1411\@ICG-J led to severe tumor damage. Therefore, compared with free ICG, the strengthened light absorption and superior stability of the ICG J-aggregate, as well as the increased tumor accumulation through the EPR effect ([@bib1], [@bib37]) and AS1411 active targeting, could indeed improve the PTT performance of the micelles.Figure 3Detecting Tumor Accumulation of the Micelles through PAI and Monitoring Temperature Changes of the Tumors in the *In Vivo* PTT Process(A) Time-dependent tumor site photoacoustic images (yellow-green scale) of the A549 tumor-bearing mice intravenously injected with various samples; the tumor boundaries were delineated by ultrasound images (gray scale). A pulsed 880-nm laser was used as excitation source, and the induced photoacoustic waves were collected by a point-focused 7.5-MHz ultrasound transducer.(B) The infrared (IR) thermography of the tumors from A549 tumor-bearing mice intravenously injected with various samples at different time points after laser irradiation (the power density of both 808- and 880-nm lasers is 0.8 W cm^−2^). In both the photoacoustic imaging and the IR thermography experiments, the intravenous injection volume of the samples is 150.0 μL; for ICG and the micelles, ICG concentration equivalent to 0.5 mg·mL^−1^.See also [Table S1](#mmc1){ref-type="supplementary-material"}, [Figures S6--S8](#mmc1){ref-type="supplementary-material"}, [S12](#mmc1){ref-type="supplementary-material"}, [S13](#mmc1){ref-type="supplementary-material"}, and [S18](#mmc1){ref-type="supplementary-material"}.Figure 4*In Vivo* Anticancer Therapy Record(A) H&E-stained slices of tumors collected from A549 tumor-bearing mice 12 h after receiving the treatments. Scale bar, 100 μm.(B) Tumor growth curves and the body weight (inset) of the mice in different groups; data are presented as the average ± SD (n = 3).(C) Photographs of mice in different groups at the end of treatments. The samples in (A--C): (i) control (without any treatment); (ii) \[-\] DOX; (iii) \[+\] PBS; (iv) \[+\] ICG; (v) \[-\] Doxil; (vi) \[-\] DSPE-PEG-1411\@ICG-J/DOX; (vii) \[+\] DSPE-PEG\@ICG-J; (viii) \[+\] DSPE-PEG-1411\@ICG-J; and (ix) \[+\] DSPE-PEG-1411\@ICG-J/DOX; \[+\] and \[-\] stand for laser-irradiated and non-laser-irradiated groups, respectively; 808-nm laser was used for group (iv) and 880-nm laser was used for the other groups. The power density of both 808- and 880-nm lasers is 0.8 W cm^−2^. In the experiment, intravenous injection volume of the samples is 150.0 μL; for ICG and the micelles, ICG concentration equivalent to 0.5 mg·mL^−1^; for DOX and Doxil, DOX concentration equivalent to 0.3 mg·mL^−1^.See also [Table S1](#mmc1){ref-type="supplementary-material"}, [Figures S6--S11](#mmc1){ref-type="supplementary-material"} and [S14--S18](#mmc1){ref-type="supplementary-material"}.

Finally, A549 tumor-bearing mice were randomly divided into nine groups to comprehensively evaluate the *in vivo* therapeutic efficacies of the micelles over a 24-day follow-up period. Groups with and without laser irradiation are marked with \[+\] and \[-\], respectively; therefore the 9 groups include: (i) control (without any treatment); (ii) \[-\] DOX; (iii) \[+\] PBS, 880-nm laser; (iv) \[+\] ICG, 808-nm laser; (v) \[-\] Doxil (a clinically approved liposomal doxorubicin formulation); (vi) \[-\] DSPE-PEG-1411\@ICG-J/DOX; (vii) \[+\] DSPE-PEG\@ICG-J, 880-nm laser; (viii) \[+\] DSPE-PEG-1411\@ICG-J, 880-nm laser; (ix) \[+\] DSPE-PEG-1411\@ICG-J/DOX, 880-nm laser. As shown in [Figure 4](#fig4){ref-type="fig"}B and 4C and [Figures S14](#mmc1){ref-type="supplementary-material"}A and B, for mice in the two control groups (i) and (iii), the tumors eventually increased 7- to 9-fold in volume. Free ICG in group (iv) exhibited poor photothermal therapeutic efficiency, which was probably due to the instability and quick metabolism of ICG molecules. After the assembly, significantly improved PTT efficiency was observed in group (vii), where the tumor growth rate was greatly inhibited (only ∼2.3-fold increase). Notably, through the introduction of AS1411 aptamer, DSPE-PEG-1411\@ICG-J in group (viii) realized complete tumor ablation at the beginning, although tumor reoccurred at the end, which demonstrated the important role of AS1411 aptamer in active targeting to enhance accumulation of micellar medicines inside tumor. As a direct evidence, the bio-distribution determination 12 h after intravenous injection of the micelles indicated that the intra-tumor accumulation efficiency of DSPE-PEG\@ICG-J was 3.00% ID·g^−1^, whereas benefiting from the active targeting ability of AS1411 aptamer, the accumulation amounts of DSPE-PEG-1411\@ICG-J and DSPE-PEG-1411\@ICG-J/DOX increased to 4.23% and 4.11% ID·g^−1^, respectively ([Figure S14](#mmc1){ref-type="supplementary-material"}C). Compared with free DOX in group (ii) and Doxil in group (v), the chemotherapeutic efficiency was greatly improved when DOX was loaded on the micelle coupled with AS1411 active targeting in group (vi), which was consistent with the histopathological tissue analysis. Free DOX and Doxil, respectively, caused negligible and slight injury to the tumor, whereas for DSPE-PEG-1411\@ICG-J/DOX in group (vi), even without laser irradiation, more visible injury to the tumor was observed ([Figure 4](#fig4){ref-type="fig"}A). To the end, \[+\] DSPE-PEG-1411\@ICG-J/DOX in group (ix), which synergistically combined active targeting, PTT, and chemotherapy, displayed the best therapeutic effect, with complete tumor elimination and no local reoccurrence during the 24-day period. The mice in all the treatment groups did not show weight loss (inset of [Figure 4](#fig4){ref-type="fig"}B) or other abnormality during the whole process, suggesting that both ICG and micelles showed negligible acute toxicity for *in vivo* applications. Subsequently, a blood circulation analysis of DSPE-PEG-1411\@ICG-J/DOX was conducted on Sprague Dawley rats; the result showed that the half-life time of the micelle in blood was ∼6.5 h ([Figure S15](#mmc1){ref-type="supplementary-material"}), whereas that of ICG is just 2--4 min ([@bib24]). This long blood circulation property can strengthen the tumor accumulation of the micelle through EPR effect ([@bib30]). Furthermore, we found that one week after the intravenous injection of DSPE-PEG-1411\@ICG-J/DOX, there was almost no ICG in the main organs of mice ([Figure S16](#mmc1){ref-type="supplementary-material"}), which means the micelles had been completely metabolized and would have no potential toxicity to the mice. The histopathological analysis and the blood routine test on the healed mice in group (ix) confirmed this inference. We found that, after the treatment, the mice showed no visible signs of damage in the main organs ([Figure S17](#mmc1){ref-type="supplementary-material"}A) and had normal blood parameters with no statistical difference to those of the healthy mice ([Figure S17](#mmc1){ref-type="supplementary-material"}B). These results convinced that, in addition to the superior therapeutic performance, DSPE-PEG-1411\@ICG-J/DOX is also a safe and reliable organic medicine without long-term toxicity and side effects.

Conclusion {#sec2.3}
----------

We revealed that through a hierarchical assembly with micelle polymer, ICG can efficiently convert to J-aggregate in several hours without a high-concentration requirement. The careful investigation demonstrated that the amphiphilic structure of the micelle and the positive charge on the micelle surface were crucial in this process, which synergistically afforded electrostatic and hydrophobic attractions to the negatively charged amphiphilic ICG molecules, so that the molecules could be concentrated and arranged in the head-to-tail fashion in the micelle. Compared with free ICG, the as-fabricated DSPE-PEG\@ICG-J complex micelle exhibited some advanced properties for cancer theranostics, including (1) an 880-nm laser with higher tissue penetration depth could be used for phototheranostics, (2) enhanced photothermal conversion resulted in a higher PTT efficiency, (3) robust photo- and bio-stability, and (4) excellent functional scalability through covalent grafting as well as physisorption. Based on DSPE-PEG\@ICG-J, a multifunctional micellar medicine, DSPE-PEG-1411\@ICG-J/DOX, was finally fabricated, which combined with J-aggregation-enhanced PTT, aptamer and EPR-effect-promoted tumor enrichment, and chemotherapy based on DOX sustained release, could promote complete tumor elimination with no local reoccurrence and without long-term toxicity or side effects during a 24-day period. To the best of our knowledge, this is the first report of controlling the J-aggregation of a classical clinical dye in polymer micelles to achieve enhanced properties. Like "old wine in a new bottle," many "old" materials, which have been developed and well studied at the molecular level, will probably show new opportunity at the supramolecular level.

Limitations of the Study {#sec2.4}
------------------------

In this study, we first report the method of controlling the J-aggregation of a cyanine dye within amphiphilic polymer micelles; however, only ICG as the cyanine dye model has been investigated. In future work, the applicability of this method to other NIR dyes and amphiphilic polymer will be investigated.

Methods {#sec3}
=======

All methods can be found in the accompanying [Transparent Methods supplemental file](#mmc1){ref-type="supplementary-material"}.
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Document S1. Transparent Methods, Figures S1--S18, and Tables S1
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